Literature DB >> 15480547

Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.

Hidesaku Asakura1, Yoko Sano, Tomotaka Yoshida, Mika Omote, Yasuo Ontachi, Tomoe Mizutani, Masahide Yamazaki, Eriko Morishita, Akiyoshi Takami, Ken-ichi Miyamoto, Shinji Nakao.   

Abstract

OBJECTIVE: We examined the role of coagulation and fibrinolysis in lipopolysaccharide (LPS) induced disseminated intravascular coagulation (DIC) in rats, studying their contribution to fibrin deposition and organ failure in rats with LPS-induced DIC by concurrent administration of low molecular weight heparin (LMWH) with or without tranexamic acid (TA).
METHODS: DIC was induced in male Wistar rats by a 4-h infusion of LPS (30 mg/kg) via the tail vein (LPS group). In the LPS+LMWH group LMWH (200 u/kg) was administered to rats from 30 min before the infusion of LPS for 4.5 h. In the LPS+LMWH+TA group LMWH (200 microg/kg) and TA (50 mg/kg) were administered to rats from 30 min before the infusion of LPS for 4.5 h.
RESULTS: In the LPS+LMWH group lower plasma levels of TAT, D dimer, creatinine, and alanine aminotransferase were observed, along with less glomerular fibrin deposition and improved survival over rats administered LPS alone. However, these effects of LMWH were completely eliminated and damage beyond that observed in rats administered LPS alone resulted from combined administration of TA (LPS+LMWH+TA group), except that TAT and D dimer levels remained lower than in the group administered LPS alone.
CONCLUSIONS: Suppression of fibrinolysis by TA (despite coadministration of LMWH) resulted in increased organ damage in this study, suggesting that depressed fibrinolysis plays a large role in organ failure resulting from LPS-induced DIC, even though hemostatic activation is moderately suppressed by LMWH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480547     DOI: 10.1007/s00134-004-2349-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  29 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.

Authors:  E K Kruithof; J C Mestries; M P Gascon; A Ythier
Journal:  Thromb Haemost       Date:  1997-05       Impact factor: 5.249

3.  Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.

Authors:  H Asakura; K Aoshima; Y Suga; M Yamazaki; E Morishita; M Saito; K Miyamoto; S Nakao
Journal:  Thromb Haemost       Date:  2001-02       Impact factor: 5.249

Review 4.  Regulation of inflammatory responses by natural anticoagulants.

Authors:  K Okajima
Journal:  Immunol Rev       Date:  2001-12       Impact factor: 12.988

5.  Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.

Authors:  G Avvisati; J W ten Cate; A Sturk; R Lamping; M G Petti; F Mandelli
Journal:  Br J Haematol       Date:  1988-09       Impact factor: 6.998

6.  Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits.

Authors:  M C Muñoz; R Montes; J Hermida; J Orbe; J A Páramo; E Rocha
Journal:  Br J Haematol       Date:  1999-04       Impact factor: 6.998

7.  Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice.

Authors:  Marcel Levi; Janine Dörffler-Melly; Pieter Reitsma; Harry Buller; Sandrine Florquin; Tom van der Poll; Peter Carmeliet
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

Review 8.  Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

Authors:  B N Bouma; J C M Meijers
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

9.  Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.

Authors:  Lianchun Wang; Jillian R Brown; Ajit Varki; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

10.  Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin.

Authors:  N Sakuragawa; H Hasegawa; M Maki; M Nakagawa; M Nakashima
Journal:  Thromb Res       Date:  1993-12-15       Impact factor: 3.944

View more
  6 in total

Review 1.  Year in review in intensive care medicine, 2004. III. Outcome, ICU organisation, scoring, quality of life, ethics, psychological problems and communication in the ICU, immunity and hemodynamics during sepsis, pediatric and neonatal critical care, experimental studies.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2005-02-18       Impact factor: 17.440

2.  Preventive application of low molecular weight heparin ameliorates peripherally inserted central catheter-related venous thrombosis.

Authors:  Liquan Huang; Guiyuan Chen; Bo Hu; Shuxia Liang; Wenya Chu; Li Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 3.  Classifying types of disseminated intravascular coagulation: clinical and animal models.

Authors:  Hidesaku Asakura
Journal:  J Intensive Care       Date:  2014-03-06

4.  Recombinant human erythropoietin attenuates hepatic dysfunction by suppressing hepatocellular apoptosis in lipopolysaccharide-induced disseminated intravascular coagulation in rats.

Authors:  Yukio Suga; Fumio Akita; Shinya Yamada; Eriko Morishita; Hidesaku Asakura
Journal:  Biomed Rep       Date:  2021-11-22

Review 5.  Tranexamic acid and trauma-induced coagulopathy.

Authors:  Takeshi Nishida; Takahiro Kinoshita; Kazuma Yamakawa
Journal:  J Intensive Care       Date:  2017-01-20

6.  Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model.

Authors:  Yzabella Alves Campos Nogueira; Loredana Nilkenes Gomes da Costa; Carlos Emilio Levy; Fernanda Andrade Orsi; Franciele de Lima; Joyce M Annichinno-Bizzacchi; Erich Vinicius De Paula
Journal:  PLoS One       Date:  2019-12-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.